Trial designed to obtain safety and efficacy data of single and multiple dosing regimen January 05, 2022 — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Company”), a clinical stage...
Read More
Event is Free; Registration is Open at Komen.org/WPBwalk January 5 2022 – The Susan G....
Read MoreThe following statement is attributable to: Gerald E. Harmon, M.D. – President, American Medical Association “Nearly two years into this pandemic, with omicron cases surging across the country, the American...
Read MoreJanuary 5 2022 – Many industry buyers discover products by seeing them in other stores or browsing through distributor catalogs, but who discovers the products in these catalogs in the first place? Innovative buyers will...
Read More
January 5 2022 – Disability services are chronically underfunded, and the problem has only...
Read More
